Articles From: Bioniche E. coli O157 Vaccine to be Used in an On-Farm Intervention Study in Sweden to BioNitrogen Corporation Signs Agreement With BioResource Management, Inc. for Management & Logistics of Biomass Feedstock


2013/4/18
Bioniche E.
Sign-up for Bioniche E. coli O157 Vaccine to be Used in an On-Farm Intervention Study in Sweden investment picks
2013/4/18
-vaccine to be used under import permit on cattle farms to control serious human illness- BELLEVILLE, ON , April 18, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that its E.
Sign-up for Bioniche E. coli O157 Vaccine to be Used in an On-Farm Intervention Study in Sweden investment picks
2013/5/13
BELLEVILLE, ON , May 13, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has engaged U.S.-based Evercore Partners (Evercore) to assist the Board of Directors and management in its divestment of the Animal Health business.
Sign-up for Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business investment picks
2013/4/26
BELLEVILLE, ON , April 26, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today acknowledged that a shareholder has requested a shareholders' meeting.
Sign-up for Bioniche Life Sciences Inc. Acknowledges Request for Shareholder Meeting investment picks
2013/4/19
Bioniche Life Sciences Inc. Experiences Increased Trading Activity Canada NewsWire -unusually high volume of trading on the TSX today- BELLEVILLE, ON, April 19, 2013 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today noted substantial trading volume of its shares on the Toronto Stock Exchange.
Sign-up for Bioniche Life Sciences Inc. Experiences Increased Trading Activity investment picks
2013/4/19
-unusually high volume of trading on the TSX today- BELLEVILLE, ON , April 19, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today noted substantial trading volume of its shares on the Toronto Stock Exchange.
Sign-up for Bioniche Life Sciences Inc. Experiences Increased Trading Activity investment picks
2013/3/26
BELLEVILLE, ON , March 26, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today provided its reaction to last week's Canadian Budget 2013.
Sign-up for Bioniche Life Sciences Inc. Reacts to Canadian Federal Budget investment picks
2013/3/27
Bioniche Life Sciences Inc. Receives Government of Canada Support for Second Generation E.
Sign-up for Bioniche Life Sciences Inc. Receives Government of Canada Support for Second Generation E. coli O157 Vaccine investment picks
2013/3/27
-second generation vaccine expected to be safer to make, with higher yields- BELLEVILLE, ON , March 27, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has received a contribution of up to $500,000 from the National Research Council of Canada Industrial Research Assistance Program (IRAP) for the Company's research and development of a second generation E.
Sign-up for Bioniche Life Sciences Inc. Receives Government of Canada Support for Second Generation E. coli O157 Vaccine investment picks
2013/4/1
Bioniche Life Sciences Inc. Regains Sponsorship of Urocidin™ Canada NewsWire About Urocidin TM Urocidin™ is a formulation of MCC, a sterile mycobacterial cell wall-DNA complex composition that has a dual mode of action: immune stimulation and direct anticancer activity.
Sign-up for Bioniche Life Sciences Inc. Regains Sponsorship of Urocidin™ investment picks
2013/4/1
BELLEVILLE, ON , April 1, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that sponsorship of its Phase III bladder cancer product - Urocidin™ - has been returned to the Company from former development/marketing partner, Endo Pharmaceuticals (Endo). It was announced in December, 2012 that Bioniche and Endo had come to an agreement whereby Endo would return global rights to Urocidin™ .
Sign-up for Bioniche Life Sciences Inc. Regains Sponsorship of Urocidin™ investment picks
2013/2/6
Bioniche Life Sciences Inc. Reports Q2, Fiscal 2013 Results Canada NewsWire -Animal Health product sales revenues are 14% ahead of Fiscal 2012 on a year-to-date basis- (all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON, Feb.
Sign-up for Bioniche Life Sciences Inc. Reports Q2, Fiscal 2013 Results investment picks
2013/5/8
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results Canada NewsWire (all figures are in Canadian dollars unless otherwise noted) TORONTO , May 8, 2013 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the third quarter of its 2013 fiscal year (ended March 31 , 2013). Management has been making concerted efforts to unlock corporate value for the benefit of all shareholders, and these efforts have been progressing on a number of fronts.
Sign-up for Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results investment picks
2013/5/8
(all figures are in Canadian dollars unless otherwise noted) TORONTO , May 8, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the third quarter of its 2013 fiscal year (ended March 31, 2013 ). Management has been making concerted efforts to unlock corporate value for the benefit of all shareholders, and these efforts have been progressing on a number of fronts.
Sign-up for Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results investment picks
2013/5/4
BELLEVILLE, ON , May 4, 2013 /PRNewswire/ - The Board of Directors of Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC) ("Bioniche" or the "Company"), on recommendation of a newly struck special committee (the "Special Committee"), announced today that, with the advice of its legal counsel, it has determined that the dissident shareholder's request for a shareholder meeting received on April 25, 2013 (the "Request"), does not constitute a valid shareholder requisition.
Sign-up for Bioniche Life Sciences Inc. Responds to Dissident Request for Shareholder Meeting investment picks
2013/4/22
BELLEVILLE, ON , April 22, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today responded to a published letter to the Board of Directors from two former Biovail Executives claiming to represent a group of concerned shareholders and suggesting that the Company engage in open dialogue with all shareholders.
Sign-up for Bioniche Life Sciences Inc. Responds to Letter from Former Biovail Executives investment picks
2013/5/29
BELLEVILLE, ON , May 29, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC) ("Bioniche"), today announced that its Board of Directors ("Board"), with the advice of legal counsel, has carefully reviewed the purported "second requisition" by Bill Wells and Greg Gubitz for a shareholders' meeting to replace the Board of Bioniche.
Sign-up for Bioniche Responds to Dissident Shareholders and Rejects Call for Early Shareholder Meeting investment picks
2013/5/22
http://media.marketwire.com/attachments/201206/47815_bionitrogen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1019979&ProfileId=051205&sourceType=1 DORAL, FL --
Sign-up for BioNitrogen Corporation Announces a $10 Million Allocation From the Florida New Markets Capital Investment Program investment picks
2013/2/5
http://media.marketwire.com/attachments/201206/47815_bionitrogen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=982186&ProfileId=051205&sourceType=1 DORAL, FL --
Sign-up for BioNitrogen Corporation Announces Convertible Debenture Financing investment picks
2013/4/2
http://media.marketwire.com/attachments/201206/47815_bionitrogen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1002866&ProfileId=051205&sourceType=1 DORAL, FL --
Sign-up for BioNitrogen Corporation Announces Supply Agreement With United Suppliers, Inc. for Plants in Pointe Coupee Parish, Louisiana investment picks
2013/4/10
http://media.marketwire.com/attachments/201206/47815_bionitrogen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1005872&ProfileId=051205&sourceType=1 DORAL, FL --
Sign-up for BioNitrogen Corporation Begins Collection of Woody Biomass for Hardee County Plant investment picks
2013/3/7
http://media.marketwire.com/attachments/201206/47815_bionitrogen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=994278&ProfileId=051205&sourceType=1 DORAL, FL --
Sign-up for BioNitrogen Corporation Begins Preliminary Work on Railroad Spur in Hardee County investment picks
2013/4/4
http://media.marketwire.com/attachments/201206/47815_bionitrogen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1003938&ProfileId=051205&sourceType=1 DORAL, FL --
Sign-up for BioNitrogen Corporation Signs Agreement With BioResource Management, Inc. for Management & Logistics of Biomass Feedstock investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Bioniche E. coli O157 Vaccine to be Used in an On-Farm Intervention Study in Sweden to BioNitrogen Corporation Signs Agreement With BioResource Management, Inc. for Management & Logistics of Biomass Feedstock
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity